January 9, 2009 Via Federal Express Document Processing Center (Mail Code 7407M) Room 6428 Attention : 8(e) Coordinator Office of Pollution Prevention and Toxics U.S.
refid# a1njjpezE4YMGMVevQL3DpG1e2 pages
Taft/ Taft Stettinius & Hollister LLP 425 Walnut Street, Suite 1800/ Cincinnati, OH 45202-3957 / Tel : 513 .381 .2838 / Fax : 513 .381 .0205 /www.taftlaw.com Cincinnati / Cleveland / Columbus / Dayton / Indianapolis / Northern Kentucky / Phoenix / Beijing ROBERT A BILOTT 513.357 .9638 bilott@taftlaw.com ~-1 "a - 01Dr 37 S ~~.aa~-3~g~ March 20, 2009 ~f~ 3f ~ ( f~ TSCA Confidential Business Information Center (7407M) I EPA East - Room 6428, Attn: Section 8(e) & FYI U.S.
refid# EdDooKEp9m9X3NDzjQQNV0m8j6 pages
a) Stpton `SSatenpchheenzIBU.S.Corporate/3M SanchezlUS-Corporatef3MI WwUS ERY 04/26f2006 02:34 PM To To cc c neebcc Sule Subject Fred J Pars US CopormA u SCaM pos Richard F.
refid# vxVmoRJGbwEpgEdzwoBn0Xa63 pages
Hiempon Geary Olsen/US-Corporate/3M/US 10/01/2007 04:19PM 1To William K.
refid# Ex10GdBk2LNzMqOzM9NxGNVoN6 pages
a -- MMiinnnneessoottaa PPoolllluuttiioonn CCoonnttrrooll AAggeennccyy a JJuullyy 1188,,22000066 CERTIFIED MAIL NO. 7005 3110 0002 5656 2476 CERTIFIED MAIL NO. 7005 3110 0002 5656 2476 RREETTUURRNN RREECCEEIIPPTT RREEQQUUEESSTTEEDD MVEinrrv..iGGraoarnrmvyeHHntooahhleennMssattneiainnger, Special Projects E33P.MnMO.viCCrBoooommmxpnpae3ann3nt3yya3l1Manager, Special Projects SBPBtu.uOiilP.ldadBuiinlno,ggxM443223N--3223E615--522177333331 St.
refid# Dv401agZzB96qjKkxk1nvVwoN5 pages
ADIETARY LS0STUDYWITH THE NORTHERN BOBWHITE PPFFOOSS:: A DIETARY LCS0 STUDY WITH THE NORTHERN BOBWH1TE `WWIILLDDLLIIFFEE IINNTTEERRNNAATTIIOONNAALL LLTTDD..
refid# 3Q205yVeB5D2j4be3QQ6pn6aE62 pages
722 FREES MMoortrtaalliittyy ooff eemmppllooyyeeeess ooff aa ppeerrtf:lluuoorrooooccttaanneessuullpphhoonnyyll fflluuoorriiddee mmaannuuffaaccttuurriinngg ffaacciilliittyy 8HAlexander, G W Olen, J MBurris, J HMondel,J Mandel B H Alexander, G W Olsen, J M Burris, l H Mandel, J S Mandel xatd 0180722729 Occup Environ Med 2003;60:722-729 Ssdspthle AeEip iFposOosbSkimToneeb gAcvedeoobrseknoioTg1ro4r t3thed:cTcyr lFofOeso]r) ncsoelid nbloeyeeltoofbicyao ydacy phhloowmes oedanecalpoon prerssomfrcet wapnipfihooobrtde,roSsoaattcdcaonPeshShepeohheYfoonc!
refid# oxp17qR8d2e66Vx2ERy5RMq78 pages
AR226-0 206 3E M nvir Labo oratn ory mental Final Report- Analytical Study Single-Dose Intravenous Pharmacokinetic Study of T-6054 in Rabbits In-Vivo Study Reference Number:HWI#6329-138 Study Number: AMDT-122094.2 Test Substance: FC-129 (T-6054) Name and Address of Sponsor: 3M SCD Division 367 Grove Street St.
refid# X7r90yDvK1VdJE9ooe5Y97XBw95 pages
fiz Sa % 3 emer FY 020). 1378 AR 226 _ 025 UNI TED STA TESWEANSVHIIRNOGNTOMNE,NTDA.CL.
refid# 4a2DVXRM3xe0KkeXQOKQ52Loa1 page
- R53 (79 4 M226 _ ops oo : R UPS OVERNIGHT DELIVERY PREPCTEWCEBDI.C CCOOMMPPAANNYYSSAANNIITIZZEEDD,,CCOONNTTAAIINNSSNNOOTTSSCCAACCBBIAARR-:228 poseFosal KIS BY December 28, 2001 2Rr 2 2 Document Control Office(7407M) UOf.fSi.ceEnovfiProolnlmuteinotnalPrPervoetnetcitoinonaAngdeTnocxyics (OPPT) EPA East, Room 6428 W1a2s0h0inPgetnonns,ylDvaCni2a04A6v0enue NW Subject: pSruobdmuicstsiioonnofofAFFluForaogseunrtfsactant Formulation for the Dear Sir/Madam: = = s ZSz gn 3=3 z 55 = O < Enclosed is sells for the the chemical formula for the productionof AFFF agents.
refid# byjpG7XGQgKm812Yb0NKDNwkk2 pages
- 5 SM avpeciany Marais Nciamersin AR 226-1057 _ wo 859 Fyz_olo2-1378 ao osvey VRRIIGGINAL O g HR January 30, 2002 = 53 DOfofciucmeoefnPtoPlrloucteisosniPnrgeCveenntteiron(a74n0d7T)oxics i= 4U0.S1.MEnSvtirreoentmSenWtal Protection Agency I Washington, D.C. 20460 FYI-00-001378 Attention: For Your Information Docket - Docket No.
refid# wg6Nn4QQV0GX89yjB334aLBpQ8 pages
329 ff AR226- 1077 DRAFT HAZARD ASSESSMENT OF PERFLUOROOCTANOIC ACID AND ITS SALTS OfUf.iSc.eEonfvPiorlolnumtieonntaPlrePvreontteicotnioannAdgTeonxciycs Risk Assessment Division February 20, 2002 es0e0i PREFACE.
refid# Yj8154q5DyQmrV1Ydmk0m8QKN339 pages
^ 6_ 36/ Management Strategy for four new fluorotelomer based substances Consultation meeting on PFCA Action Plan February 2006 000065 Overview Need for Action Exposure Sources Considerations Proposed Objectives Proposed Risk Management Actions Next Steps Page 2 000066 p to Need for Action Assessment of four new fluorotelomer based substances notified under New Substances Notification Regulations Concerns: Sources o f long-chain PFCAs : persistent, bioaccumulative, adverse effects, increasing concentrations in Arctic mammals.
refid# 9J4LxqdVxag0jzv2y4gavL61D9 pages
TSCA Document Processing Center Attn: Section 8(e)/FYI M2.Z6 - 373V August 10,2006 Page 4 of 10 Attachment 1 July 19, 2006 "Note for settling parties" from the Science Panel (1 page) Note for settling parties We have prepared some outline protocols for several interlinked research components addressing the potential health effects of exposure to C8 around the Washington Works plant.
refid# k9Eqvdk1omMZZ2Q2mp1ZJ6vKb1 page
September 29,2006 Page 3 ATTACHMENT 2 Tables and excerpts from the draft protocols that contain raw data C-8 blood levels.
refid# jmeem206B4B6m7aEnLx6ZrzJ23 pages